The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience, and improved drug compliance.
What the Market Looks Like?
The global digital therapeutics market is projected to reach USD 6.9 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 26.7% during the forecast period (2020–2025). North America accounted for the largest share of the digital therapeutics market in 2019.
A lack of awareness and access to digital therapeutics programs in developing countries, patient data privacy concerns, unstable payment models, and resistance from traditional healthcare providers are challenging the growth of this market to a certain extent.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51646724
What are Key Trends in the Market?
The growth of the Digital Therapeutic (DTx) Market is primarily influenced by the following factors:
- Increasing incidence of preventable chronic diseases
- Rising focus on preventive healthcare
- Need to control healthcare costs
- Significant increase in venture capital investments
Based on the type of buyer, the B2C sales channel market is further segmented into patients and caregivers. The caregivers segment is expected to dominate the market and register the highest CAGR during the forecast period. The high growth of this segment is attributed to company initiatives for the development of products specifically for caregivers and the fact that digital therapeutics help caregivers in better managing their patients.
Read more about DTx Market @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=51646724